Essity stock faces PFAS lawsuit over Carefree panty liners

Published on 11/02/2026 at 09:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Essity stock faces legal scrutiny over Carefree panty liners in California. Essity rejects the central allegation and plans a vigorous response.

Legal Risk Reaches Carefree Brand

Hundreds of Los Angeles County residents accuse Carefree makers of violating California restrictions on intentionally added PFAS.
Essity says it does not intentionally add PFAS to Carefree products and plans to respond vigorously.
The case adds a litigation risk to Essity's recently expanded feminine care business.

Essity B, SE0009922164, Illustration mit AI erstellt.

Essity is facing a new legal risk in its North American feminine care business after hundreds of Los Angeles County residents accused the makers of Carefree panty liners of violating California's PFAS restrictions. Manufacturing Dive reported that court documents were filed on October 9, 2026, in the Superior Court of Los Angeles County.

The plaintiffs allege that Carefree products were intentionally made with perfluorooctanoic acid, or PFOA, a chemical in the PFAS group. They also accuse Essity, Edgewell and Johnson & Johnson of manufacturing and distributing the products after California's ban on the manufacture, sale and distribution of menstrual products intentionally made with PFAS took effect on January 1, 2025. Gelson's Markets is also named in the case over the alleged sale of the products.

Claims Remain Unproven In Court

The lawsuit cites an independent laboratory test from 2024 that allegedly found PFOA in one or more of five Carefree product layers. The filing claims repeated use caused a range of health problems and alleges that the companies failed to disclose the chemical or provide warnings. Those allegations have not been established by a court.

Essity spokesperson Amy Bellcourt said Carefree stands behind its products and that the company does not intentionally add PFAS chemicals to them. She said PFAS are not an ingredient used in making Carefree products, added that ingredients are printed on the packaging and said Essity intends to respond vigorously to the claims.

Essity acquired Edgewell's North American feminine care business in February 2026, bringing Carefree and other brands into its portfolio. The litigation therefore puts attention on product compliance and potential legal costs as the group integrates the business. The case is an allegation, not a finding of liability, but it creates a fresh risk for the unit's reputation and operating outlook.

Essity stock traded at 25.57 euros on Lang & Schwarz at 09:36 CET on Monday, November 2, 2026; see the real-time quote of Essity stock.

Swedish investors will also monitor broader consumer-goods sentiment through the OMXS30 market environment.

Further developments will depend on Essity's response, the court's handling of the claims and any evidence concerning the products at issue. More news and analyses on Essity stock.